(Reuters) -The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and ...

George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.

Eli Lilly’s star oral GLP-1 candidate orforglipron and Novo Nordisk’s Wegovy (semaglutide) were named voucher winners in a ...

The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.

Here’s what you need to know about the “mystery liquids” being sold to cost-cutters and unqualified injectors.

The FDA announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to ...

Senate Democrats warned the Trump administration against imposing additional restrictions on access to abortion pills in ...

FDA issues Class II recall for ADHD drug after quality concerns, with millions of prescriptions potentially impacted.

After a three-month delay, the FDA has now rejected an approval request based on the RWE. According to Biohaven, the FDA’s complete response letter “cited issues that can be inherent to real-world ...

Tenaya Therapeutics said on Friday the U.S. Food and Drug Administration has placed a clinical hold on its trial of an ...

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial ...